Agenda
Monday, April 15, 2019
KEYNOTE ADDRESS
Arlene H. Sharpe, MD, PhD, Harvard Medical School
GASTRONINTESTINAL TOXICITES
SESSION MODERATOR: MICHAEL DOUGAN, MD, PHD
Michael Dougan, MD, PhD, Massachusetts General Hospital
Erez Baruch, MD, Sheba Medical Center
Robert S. Bresalier, MD, MD Anderson Cancer Center
MOONSHOT ADMINISTRATIVE SUPPLEMENT
AWARDEE UPDATE
Mark Anderson, MD, PhD, University of California, San Francisco
CYTOKINES, AUTOIMMUNITY, AND IMMUNE RELATED ADVERSE EVENTS REFRACTORY TO INITIAL THERAPY
SESSION MODERATOR: ELAD SHARON, MD, MPH
Jarushka Naidoo, MBBCh, Johns Hopkins University
Kelly Walkovich, MD, C. S. Mott Children’s Hospital
David Klatzmann, MD, PhD, Hôpital Pitié-Salpêtrière, Sorbonne Université
NEUROLOGICAL AND OCULAR TOXICITIES
SESSION MODERATOR: DAVID HAFLER, MD, FANA
David Hafler, MD, FANA, Yale School of Medicine
Bianca D. Santomasso, MD, PhD, Memorial Sloan Kettering Cancer Center
Hatice Nida Sen, MD, MHS, National Eye Institute
KEYNOTE ADDRESS
Elizabeth M. Jaffee, MD, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
COMBINATION THERAPIES
SESSION MODERATOR: ELIZABETH JAFFEE, MD
Elizabeth M. Jaffee, MD, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Jonathan D. Schoenfeld, MD, MPhil, MPHD, Dana-Farber Cancer Institute
Nicole Drezner, MD, U.S. Food and Drug Administration
ADJOURN
Tuesday, April 16, 2019
SKIN TOXICITIES AND RHEUMATOLOGY
SESSION MODERATOR: ROBERT CARTER, MD
Xavier Mariette, MD, PhD, Hôpital Bicêtre, Université Paris-Sud
Blake Warner, DDS, PhD, MPH, National Institute of Dental and Craniofacial Research
Nicole LeBoeuf, MD, MPH, Dana-Farber Cancer Institute
Antony Rosen, MBChB, MD, Johns Hopkins Medicine
PANEL DISCUSSION
BREAK
MOONSHOT ADMINISTRATIVE SUPPLEMENT
AWARDEE UPDATE
Stephanie Watowich, PhD, MD Anderson Cancer Center
THE BIG PICTURE: APPROACHING IMMUNE-RELATED ADVERSE EVENTS FROM MULTIPLE DATA STREAMS
SESSION MODERATOR: GIORGIO TRINCHIERI, MD
Douglas B. Johnson, MD, Vanderbilt-Ingram Cancer Center
David Kozono, MD, PhD, Dana Farber Cancer Institute
Meredith Chuk, MD, U.S. Food and Drug Administration
LUNCH BREAK
KEYNOTE ADDRESS
Jennifer Wargo, MD, MMSc, MD Anderson Cancer Center
PANEL DISCUSSION
CELL-BASED IMMUNOTHERAPY
David L. Porter, MD, University of Pennsylvania Perelman School of Medicine
Michael Milone, MD, PhD, University of Pennsylvania Perelman School of Medicine
BREAK
NON-CLINICAL MODELS
SESSION MODERATORS:
JOHN LEIGHTON, PHD AND JULIE SCHNEIDER, PHD
Jeff Bluestone, PhD, Parker Institute for Cancer Immunotherapy
Gregory L. Beatty, MD, PhD, University of Pennsylvania
Pan Zheng, MD, PhD, University of Maryland, Baltimore
Kristina E. Howard, DVM, PhD, U.S. Food and Drug Administration
PANEL DISCUSSION